Effects of Cyproheptadine on Mitral Valve Remodeling and Regurgitation After Myocardial Infarction

Ons Marsit,Marie-Annick Clavel,Amélie Paquin,Valérie Deschênes,Sandra Hadjadj, Isabelle Sénéchal-Dumais,Jacques Couet,Marie Arsenault,Mark D Handschumacher,Robert A Levine,Elena Aikawa,Philippe Pibarot,Jonathan Beaudoin

Journal of the American College of Cardiology（2022）

引用 4|浏览29

暂无评分

摘要

Cyproheptadine given after inferior MI reduces post-MI 5-HT levels, prevents valvular fibrotic remodeling, is associated with larger increase in mitral valve size and less MR.

查看译文

关键词

5-hydroxytryptamine 2 receptor antagonist,cyproheptadine,mitral regurgitation,mitral valve,myocardial infarction,serotonin

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要